Stocktoria
MADRIGAL PHARMACEUTICALS, INC. MDGL
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2007-02-06
MADRIGAL PHARMACEUTICALS, INC. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Taub Rebecca | director | 2026-06-17 | Grant | 454 | — |
| FOUSE JACQUALYN A | director | 2026-06-17 | Grant | 454 | — |
| Levy Richard S | director | 2026-06-17 | Grant | 454 | — |
| Brennan Daniel J. | director | 2026-06-17 | Grant | 404 | — |
| BAKER BROS. ADVISORS LP | director | 2026-06-17 | Grant | 908 | — |
| BAKER BROS. ADVISORS LP | director | 2026-06-17 | Grant | 908 | — |
| Daly James M | director | 2026-06-17 | Grant | 454 | — |
| Soergel David | Chief Medical Officer | 2026-06-01 | Sell | 1,042 | $495.74 |
Source: SEC EDGAR filings · CIK 0001157601 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.